
Sign up to save your podcasts
Or


Covering a very interesting study this week, which investiaged the PDE4B inhibitor nerandomilast for patients with progressive pulmonary fibrosis (specifically including 325 patients with autoimmune ILD). Would have been yet another ho hum trial if not for the big reveal... have a listen to find out!
Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2503643
By Michael Putman4.9
114114 ratings
Covering a very interesting study this week, which investiaged the PDE4B inhibitor nerandomilast for patients with progressive pulmonary fibrosis (specifically including 325 patients with autoimmune ILD). Would have been yet another ho hum trial if not for the big reveal... have a listen to find out!
Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2503643

506 Listeners

299 Listeners

124 Listeners

3,360 Listeners

1,152 Listeners

120 Listeners

197 Listeners

517 Listeners

68 Listeners

4 Listeners

373 Listeners

182 Listeners

188 Listeners

17 Listeners

6 Listeners